Brian Miglionico '04

After his time at CHA, Brian studied at Northeastern University and worked at Acceleron Pharma for nine years. In 2016, he joined Finch Therapeutics' founding team and launched a microbiome biotech. Brian has successfully supported the growth of the company from 10 to 150 employees through strategic partnerships and fundraising activities. The microbiome field is in its infancy; however, it is gaining traction and focus from investors and large pharma companies alike. They (and many others) have been working to blaze a path in an otherwise uncharted therapeutic landscape and see broad application to modulate many unmet disease indications through the microbiome and gut bacteria.